Galapagos GAAP EPS of Euro4.87, revenue of Euro1.11B; introduces Q1 and FY26 outlook
Source: SeekingAlpha
2026-02-23 23:32:56 ET
More on Galapagos
- Galapagos: Pivoting From Clinical Risk To Strategic Capital Allocation
- Galapagos meets primary goal in phase 3-enabling study for rare autoimmune disease asset
- Seeking Alpha’s Quant Rating on Galapagos
- Historical earnings data for Galapagos
- Financial information for Galapagos
Read the full article on Seeking Alpha
For further details see:
Galapagos GAAP EPS of €4.87, revenue of €1.11B; introduces Q1 and FY26 outlook
Galapagos Genomics Ord
NASDAQ: GLPGF
GLPGF Trading
0.0% G/L:
$34 Last:
1,000 Volume:
$34 Open:
GLPGF Latest News
February 23, 2026 04:01:00 pm
Galapagos Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
GLPGF Stock Data
$2,214,141,586
49,160,084
N/A
238
N/A
Biotechnology & Life Sciences
Healthcare
BE
Mechelen
